MedPath

Tetrofosmin

Tetrofosmin (for the preparation of Tc99m Tetrofosmin injection)

Approved
Approval ID

c19c8ed9-24ea-48a2-ad37-3fa3dfd15f06

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 23, 2012

Manufacturers
FDA

AnazaoHealth Corporation

DUNS: 011038762

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tetrofosmin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51808-223
Product Classification
G
Generic Name
Tetrofosmin
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJuly 2, 2012
FDA Product Classification

INGREDIENTS (4)

TETROFOSMINActive
Quantity: 0.35 mg in 1 1
Code: 3J0KPB596Q
Classification: ACTIB
DISODIUM SULFOSALICYLATEInactive
Quantity: 0.48 mg in 1 1
Code: WFP6MAA96R
Classification: IACT
SODIUM BICARBONATEInactive
Quantity: 2.7 mg in 1 1
Code: 8MDF5V39QO
Classification: IACT
GLUCONIC ACIDInactive
Quantity: 1.5 mg in 1 1
Code: R4R8J0Q44B
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tetrofosmin - FDA Drug Approval Details